The aim of this study is to utilize biomimetic nanovesicles loaded with PEBP1 mRNA to activate the NRF2/GPX4 axis, inhibit ferroptosis in VSMCs, and prevent the formation of AAA. Here, GPX4 is linked to triple-A syndrome.